Literature DB >> 26496749

The molecular mechanism of CRISPR/Cas9 system and its application in gene therapy of human diseases.

Liang Qu1, Hua-shan Li1, Yun-han Jiang1, Chun-sheng Dong1.   

Abstract

CRISPR/Cas system is an adaptive immune system that confers resistance to exogenous virus or plasmid in bacteria and archaea. In recent years, the booming CRISPR/Cas9 genome editing technology modified from type2 CRISPR/Cas adaptive immune system has been widely applied to various research fields of life science and led to revolutionary changes. In this review, we summarize the origin and development of CRISPR/Cas9 genome editing technology as well as its applications in life science research. We focus on the latest application of this system in gene therapy of human diseases and the associated side/off-target effects, which may provide references for researchers in related areas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26496749     DOI: 10.16288/j.yczz.15-109

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  2 in total

1.  Efficient Delivery and Nuclear Uptake Is Not Sufficient to Detect Gene Editing in CD34+ Cells Directed by a Ribonucleoprotein Complex.

Authors:  Shirin R Modarai; Dula Man; Pawel Bialk; Natalia Rivera-Torres; Kevin Bloh; Eric B Kmiec
Journal:  Mol Ther Nucleic Acids       Date:  2018-02-07       Impact factor: 8.886

Review 2.  The CRISPR/Cas Genome-Editing Tool: Application in Improvement of Crops.

Authors:  Surender Khatodia; Kirti Bhatotia; Nishat Passricha; S M P Khurana; Narendra Tuteja
Journal:  Front Plant Sci       Date:  2016-04-19       Impact factor: 5.753

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.